The Prevalence of Cardiovascular Disease Risk Factors on Diabetic Human Immunodeficiency Virus‐Infected Individuals on Antiretroviral Treatment: A Systematic Review and Meta‐Analysis Protocol

Documenti analoghi

• Prevalence of metabolic dysfunction‐associated steatotic liver disease in people living with HIV and on antiretroviral treatment: A systematic review and meta‐analysis protocol
  di: Amogelang Sedibe, et al.
  Pubblicazione: (2024)
• The Impact of Selected Regimens of Chronic HIV‐Antiretroviral Treatment on Glycemic Control Markers and Correlates: A Systematic Review and Meta‐Analysis Protocol
  di: Mlindeli Gamede, et al.
  Pubblicazione: (2025)
• Influence of Dietary Diversity and Its Associated Factors Among Human Immunodeficiency Virus–Infected Adult Patients Receiving Antiretroviral Therapy in Northwest Ethiopia
  di: Yihenew Sewale, et al.
  Pubblicazione: (2025)
• Efficacy, Effectiveness, and Safety of Treatment Regimens for Histoplasmosis and Tuberculosis Coinfection in Patients With Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: A Systematic Review With Meta‐Analysis Protocol
  di: Beatriz Bernava Sarinho, et al.
  Pubblicazione: (2026)
• Main Protease From SARS‐CoV‐2 Dysregulates Glucose Handling in the C2C12 Cell Line In Vitro: A Mechanistic Study
  di: Praise Tatenda Nhau, et al.
  Pubblicazione: (2026)